Thursday, October 6, 2022 | Back issues
Courthouse News Service Courthouse News Service

GlaxoSmithKline Settles for $600 Million

JEFFERSON CITY, Mo. (CN) - GlaxoSmithKline will pay $600 million to settle claims that it sold adulterated drugs. The Missouri Medicaid program will get $9 million of it, through the federal government, with $3.5 million going to the state itself.

SB Pharmaco, a GlaxoSmithKline subsidiary in Puerto Rico that made the bad drugs, will pay $150 million in criminal fines and forfeitures, Attorney General Chris Koster announced.

The settlement came out of a 2004 complaint in Massachusetts that claimed GlaxoSmithKline knowingly made, distributed and sold products that fell below Federal Drug Administration standards. The products included Paxil CR, Vandamet, Kytril and Bactroban.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.